Weight Loss Surgery: Individualized Approach to Biometabolic Outcomes

This study is looking at how different lengths of the bypassed intestine during weight loss surgery (Roux-en-Y gastric bypass) affect weight loss and overall health. Researchers are comparing three different lengths: 50 cm, 100 cm, and 150 cm. They want to understand if increasing the bypassed intestine length can lead to better results and how it changes your body's biology and metabolism. This research aims to improve treatments for obesity and related conditions like metabolic syndrome and NASH (a type of liver disease). You might be able to join if you are between 18 and 80 years old, have a Body Mass Index (BMI) between 40-60 kg/m2, and meet your insurance's criteria for weight loss surgery. The study is still recruiting participants.

Study design
This is an interventional study planning to enroll 750 participants. It compares three different surgical procedures (50 cm, 100 cm, or 150 cm biliopancreatic limb length).
What's involved
You would need to have blood collected before and after surgery at specific times, and collect and mail a stool sample before the operation.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 7 years to measure weight loss and complications after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04841057

Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach

Enrolling by Invitation
NAAges 18–80InterventionalBasic science
University of Missouri-Columbia
~750 participants
Updated 2025-08-01 on ClinicalTrials.gov
What's tested:50 cm BP limb length100 cm BP limb length150 cm BP limb length

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Weight loss after Variable Biliopancreatic Limb Length Bypass
Measured over 7 years
+1 more outcome measured
Obesity, Morbid
Metabolic Syndrome
NASH - Nonalcoholic Steatohepatitis
1 sites across 1 states
Missouri1
  • Andrew Wheeler, MD · PRINCIPAL_INVESTIGATOR · University of Missouri-Columbia, Department of Surgery

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Weight loss after Variable Biliopancreatic Limb Length Bypass7 years

    Evaluation of weight loss after modifications to the length of BP limb length

  • Complications after Variable Biliopancreatic Limb Length Bypass7 years

    Evaluation of weight loss after modifications to the length of BP limb length